Department of Psychiatry and Psychotherapy

This study examines substance use and sexualizes substance use among people with attention deficit hyperactivity disorder (ADHD) in a completely anonymous manner.  You are also welcome to participate if you have ADHD and do not use substances.  You can find more detailed information here.

Adults with ADHD and moderate to severe depression are being sought for a study investigating the safety and efficacy of the drug dexamfetamine sulfate. More information about the study can be found here.

The study is aimed at people affected by borderline personality disorder (BPD) or attention deficit/hyperactivity disorder (ADHD). Its goal is to find out whether the drug BI 3031185 can help people with BPD or ADHD. You can find more information here.

Innovative pitches and AI impulses shape the day The MIB Future Panel 2025, organized by the Medical Imaging Center Bonn (MIB) and the Transfer Team of the Bonn Medical Faculty, once again provided an exciting platform for exchange between science, clinics, start-ups, industry, and investors on October 2—with a special focus on medical imaging and artificial intelligence (AI). The highlight was the “Medical Pitch Contest Bonn,” in which ten teams from the Medical Faculty of Bonn competed for prize money totaling €60,000 in front of 180 guests and renowned investors.Read more

Researchers in Bonn investigate the influence of ADHD traits on stock trading decisions ADHD traits not only affect school and work, but also financial behavior. Researchers at the University Medical Center Bonn (UKB) and the University of Bonn have shown that more severe ADHD traits are associated with a higher willingness to take risks, more frequent speculative trading behavior, and lower average returns. Inattention is a particularly important factor in unfavorable trading decisions, for example, through careless mistakes or difficulties in planning and decision-making. The results were recently published in the journal Scientific Reports. More information can be found here.

DEXINA—Drug treatment for adults with ADHD (Attentin®). This study is aimed at patients who are at least 18 years old and have ADHD. More information about the DEXINA clinical study can be found here.

The ChangePDD clinical study aims to improve psychotherapy for patients with chronic depression. It helps to expand our knowledge of how psychotherapy works so that treatment can be tailored to individual needs. You can find more information here.

Starting in fall 2024, the Clinic and Polyclinic for Psychiatry and Psychotherapy at the University Hospital Bonn will offer free group psychotherapy to reduce aggression, anger, and irritability. The therapy is part of a study funded by the German Research Foundation (DFG) and offered at various clinics in Germany. More information can be found here.

The PSY-PGx clinical study is an international research project funded by the European Union that aims to compare conventional and genetically based medication dosing. You can find more information here.